Coronavirus

ENSERVCO ALERT: Bragar Eagel & Squire, P.C. is Investigating Enservco Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, January 10, 2024

Our investigation concerns whether the board of directors of Enservco have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Enservco have breached their fiduciary duties to the company.
  • Enservco, through its subsidiaries, provides well enhancement and fluid management services to the onshore oil and natural gas industry in the United States.
  • Recently, the Company has employed several tactics in an apparent effort to strengthen its balance sheets.
  • On February 3, 2021, Enservco exchanged the remaining 50% of its subordinated debt with Cross River Partners.

Mesabi Trust Press Release

Retrieved on: 
Friday, January 12, 2024

The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of thirty-seven cents ($0.37) per Unit of Beneficial Interest payable on February 20, 2024 to Mesabi Trust Unitholders of record at the close of business on January 30, 2024.

Key Points: 
  • The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of thirty-seven cents ($0.37) per Unit of Beneficial Interest payable on February 20, 2024 to Mesabi Trust Unitholders of record at the close of business on January 30, 2024.
  • The Trustees’ announcement today of a thirty-seven cents ($0.37) per Unit distribution, as compared to no distribution announced by the Trust at the same time last year, is primarily attributable to the restart of Northshore operations in April 2023, and to an increase in the total royalties received by the Trust in October 2023, as compared to the total royalties received by the Trust in October 2022.
  • Quarterly royalty payments from Northshore for iron ore production and shipments during the fourth calendar quarter, which are payable to Mesabi Trust under the royalty agreement, are due January 30, 2024, together with the quarterly royalty report.
  • After receiving the quarterly royalty report, Mesabi Trust plans to file a summary of the quarterly royalty report with the Securities and Exchange Commission in a Current Report on Form 8-K.

Comporium Invests More Than $1,750,000 Expanding Fiber Network in Rural Lancaster County

Retrieved on: 
Wednesday, January 10, 2024

During 2023, the company continued its work to upgrade its network in rural areas of the county.

Key Points: 
  • During 2023, the company continued its work to upgrade its network in rural areas of the county.
  • The completed projects required over $1,750,000 of investment and will improve the quality of life for 274 homes and businesses.
  • This approach ensures that the company can reach the maximum number of addresses with its state-of-the-art network.
  • Comporium continues to work with state and federal agencies to find ways to upgrade service to rural customers.

A UNIVERSAL CORONAVIRUS VACCINE COULD SAVE BILLIONS OF DOLLARS IF READY BEFORE NEXT PANDEMIC

Retrieved on: 
Thursday, January 11, 2024

NEW YORK, Jan. 11, 2024 /PRNewswire/ -- What if scientists had developed a universal coronavirus vaccine in the years prior to 2020 so that it was available at the start of the COVID-19 pandemic? A universal coronavirus vaccine targets parts of the virus that are common to either many or all coronaviruses, thereby offering some degree of protection against a range of strains. A new study suggests if such a vaccine were available at the start of the pandemic, it could have saved millions of lives, prevented suffering, and saved billions of dollars in direct medical and other costs until the strain-specific (i.e., SARS-CoV-2) vaccine went through the entire development, testing, and emergency use authorization process that lasted 10 months.

Key Points: 
  • NEW YORK, Jan. 11, 2024 /PRNewswire/ -- What if scientists had developed a universal coronavirus vaccine in the years prior to 2020 so that it was available at the start of the COVID-19 pandemic?
  • A universal coronavirus vaccine targets parts of the virus that are common to either many or all coronaviruses, thereby offering some degree of protection against a range of strains.
  • The experiments simulated what would happen if a universal coronavirus vaccine was available at the start of the COVID-19 pandemic.
  • A universal coronavirus vaccine was also shown to be highly cost-effective even if a more specific and more efficacious vaccine came to market.

URBN Reports Record Holiday Sales and Personnel Update

Retrieved on: 
Monday, January 8, 2024

The increase in Retail segment comparable net sales was driven by high single-digit positive growth in digital channel sales and low single-digit positive growth in retail store sales.

Key Points: 
  • The increase in Retail segment comparable net sales was driven by high single-digit positive growth in digital channel sales and low single-digit positive growth in retail store sales.
  • Wholesale segment net sales increased 15% driven by an increase in Free People wholesale sales primarily due to increases in sales to department stores and specialty accounts, partially offset by a decrease in Urban Outfitters wholesale sales.
  • The increase in Retail segment comparable net sales was driven by high single-digit positive growth in digital channel sales and mid single-digit positive growth in retail store sales.
  • Wholesale segment net sales decreased 4%, driven by a decrease in Free People wholesale sales primarily due to a decrease in sales to department stores.

miRNA Sequencing And Assay Market Research Report 2023: Global Size, Share & Trends Analysis and Forecasts to 2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 8, 2024

The "miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report By Product & Service (Library Preparation Kits), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report By Product & Service (Library Preparation Kits), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global miRNA sequencing and assay market size is expected to reach USD 823.5 Million by 2030, registering a CAGR of 13.3% from 2023 to 2030.
  • Thus, miRNA sequence analysis is significantly employed for gene regulation analysis in clinical disorders.
  • For instance, an article published in frontiers, in March 2022, stated that blood-based miRNA biomarkers could be used to correlate brain-based miRNA expression.

Tecogen Launches Self-Learning Intelligent Control for Cogeneration Systems

Retrieved on: 
Monday, January 8, 2024

WALTHAM, MA, Jan. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Tecogen Inc. (OTCQX: TGEN), a clean energy company providing ultra-efficient and clean on-site power, heating and cooling equipment, is pleased to announce that Tecogen has been developing and testing machine learning based intelligent control for cogeneration and cooling systems.

Key Points: 
  • WALTHAM, MA, Jan. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Tecogen Inc. (OTCQX: TGEN), a clean energy company providing ultra-efficient and clean on-site power, heating and cooling equipment, is pleased to announce that Tecogen has been developing and testing machine learning based intelligent control for cogeneration and cooling systems.
  • This is a benefit for the customer and Tecogen as it increases customer savings and Tecogen’s service revenue.
  • The capacity from multiple cogeneration systems can be aggregated and receive utility payments which can be shared with the customer.
  • Since the self-learning intelligent control system is built on our remote monitoring platform it can also be integrated with other distributed generation and cooling products.

UK urged to get ready for disaster with new national crises plan – but our research reveals the dark side of prepping

Retrieved on: 
Wednesday, January 3, 2024

Preppers – those who store food, water and supplies to survive impending disaster – have a bit of an image problem.

Key Points: 
  • Preppers – those who store food, water and supplies to survive impending disaster – have a bit of an image problem.
  • Ridiculed for their delusional end-of-the world outlook, they are caricatured as “tin foil hat-wearing loons”.
  • Recently, we’ve seen energy companies warn about blackouts, urging people to plan for when the lights go out.
  • In the run up to Britain’s exit from the EU, for example, fears arose surrounding the collapse of supply chains.

Women, responsibility and division

  • Domestic and emotional issues fall squarely on mothers who are tasked with keeping households running, no matter the circumstances.
  • Whether ensuring everyone eats during shortages or soothing worries when the lights go out, women carry an outsized caretaking burden pivotal to family survival.
  • Recommendations around resilience underestimate the invisible and emotional labour needed to implement contingency planning, scanning the horizon for the next crisis.
  • These are the mothers mostly likely to possess the wealth, time, skills and physical space to prep.

Those left out

  • Their survival is likely focused on the everyday, rather than planning for a possible eventuality.
  • Inevitably, they will need wider support from the community, which the resilience framework, given its individualised approach to risk, does not fully consider.
  • What duty do neighbours have to share with others if catastrophe (or even a temporary glitch) occurs?


The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Emergex Announces Authorisation from Philippines FDA to Initiate Phase I-II Clinical Trial of CoronaTcP™

Retrieved on: 
Wednesday, January 3, 2024

Emergex received authorisation from the Philippines FDA to launch a Phase I-II clinical trial of CoronaTcP, its T cell-priming immune set-point candidate against Betacoronaviruses.

Key Points: 
  • Emergex received authorisation from the Philippines FDA to launch a Phase I-II clinical trial of CoronaTcP, its T cell-priming immune set-point candidate against Betacoronaviruses.
  • Emergex is progressing trial initiation plans, with an anticipated start date in Q2 2024.
  • The naNO-COVID 2 trial (NCT05633446) is a randomized, double-blind, placebo-controlled Phase I-II trial in the Philippines, which will investigate the safety and immunogenicity of CoronaTcP.
  • Professor Thomas Rademacher, Co-Founder and Chief Executive Officer, Emergex, commented: “We thank the Philippines FDA for rapidly approving this trial after a successful Phase I clinical trial in Switzerland.

Luis de Guindos: Interview with 20 Minutos

Retrieved on: 
Wednesday, January 3, 2024

Communication shocks from the US spill over to risk in the euro area and vice versa, but traditional US shocks show no spillover effects to risk.

Key Points: 
  • Communication shocks from the US spill over to risk in the euro area and vice versa, but traditional US shocks show no spillover effects to risk.
  • Both monetary policy and communication shocks spill over to stocks, with euro area information spillovers being particularly strong.